Transasia Bio-Medicals Ltd awarded ISO 13485

Transasia Bio-Medicals Ltd, leader in the Clinical Diagnostics Segment across the Indian healthcare sector, which aids in diagnosing life threatening diseases faced by the humankind such as, AIDS, Tuberculosis, Cancer and Diabetes etc. has been awarded ISO 13485 (Quality Management Systems for Medical Devices) by UL India, a certifying body to foster quality assurance and improvement.

Mumbai, Maharashtra, IND, 2008-02-07 17:01:06 (IndiaPRwire.com)
Downloads
  • No files attached

Transasia Bio-Medicals Ltd, leader in the Clinical DiagnosticsSegment across the Indian healthcare sector, which aids in diagnosing life threatening diseases faced by the humankind such as, AIDS, Tuberculosis, Cancer and Diabetes etc. has been awarded ISO 13485 (Quality Management Systems for Medical Devices) by UL India, a certifying body to foster quality assurance and improvement.

UL India is an affiliate of Underwriters Laboratories Inc., USA., which is one of the world's largest Conformity Assessment Service Provider.

Transasia Bio-Medicals Ltd is one of the few Indian companies which has been awarded the ISO 13485. The certification has reinforced the vision of the company to provide quality medical diagnostic products & services at Affordable prices, through Cost and Quality conscious systems of Materials and Process Control.

Transasia has always recognized Quality & R&D as the prime drivers of innovation and leadership and strives to be among the top ten diagnostic players in the world. Transasia's young and enthusiastic team of experts in software, mechanical engineering, electronics and embedded software and Bio-chemistry has built an impressive track record of successful projects. The Research and Development department, a team of 90 research and development engineers, constantly work to bring out products with appropriate technology and features to meet the changing customer needs.

The total Indian healthcare sector is valued at US$ 34 billion and is projected to grow to nearly US$ 40 billion by 2012. The diagnostic and pathology market is around 2% of the overall healthcare market. The diagnostic market has been growing at 15-20% and by all indications shall continue to grow for another 10 years at this rate. One of the major drivers has been the basic demographic change in India, the migration to urban cities and more & more people having access to modern healthcare. Impetus has also been provided by the increasing investments in hospitals, clinical laboratories and automated chemistry labs.

The world faces many challenges in the form of serious diseases and Transasia’s journey continues to provide much of the technology to diagnose the diseases earlier and save precious lives and reinforce the adage “Prevention is definitely better than cure”.

- End -

About Transasia Bio-Medicals Ltd :

TRANSASIA BIO-MEDICALS LTD.is a leader in the Clinical DiagnosticsSegment across the Indian healthcare sector, providing Total Solutions for Clinical Diagnosis. With an enviable 29-year track record in the Industry, the company is the largest Indian Manufacturer and Exporter of Diagnostic instruments. The Company has successfully developed and manufactured hi-tech In-Vitro Diagnostic (IVD) instruments & Reagents and has become a name to reckon with, in India and 54 countries across the world. With no glitter of any foreign name attached, TRANSASIA’s success is totally based ontotal commitment to the customers for providing them with Quality products and services.

From its modest beginning in 1979 as a marketing firm for a few imported diagnostic equipments TRANSASIA today has the largest Sales and Installation base with over 15000, installations all over the country supported by a network of85 service centers and Zonal offices at metros & major cities backedby a strong force of trained engineers and customer training personnel.

Transasia is the first Indian company to manufacture & export sophisticated state of the art Blood analyzers and Reagents. The company today produces world class equipments which are sold not only in India, but also exported to countries such as GERMANY, CHINA, KOREA, AUSTRALIA, GREECE, TAIWAN, NETHERLANDS, TURKEY & USA.

Transasia has strategic alliances with some leading names in the diagnostic world like Sysmex Corporation-Japan, Medica-U.S.A, Wako-Japan, Biohit-Finland,Grifols-Spain,CAN Ag-Sweden and Diesse-Italy among others.

The Company which is ISO 9001:2000 certified has also been rated as India’s largest In-vitro Diagnostics Company (2006) by McEvoy & Farmer, U.S.A. (International Experts on IVD Markets).

The long and arduous journey has been marked by awards and recognition from private, public and Government institutions like:

· Mr. Suresh Vazirani, CMD, Transasia, conferred with Indira Super Achiever Award from Indira Group of Institutes - 2006

· “Niryat Shree” for excellence in Exports” from FIEO, Ministry of Commerce – 2006

· ‘Most Promising SME and ‘Emerging India Awards’ from CNBC - 2005

· National R&D award for technology innovation, development and successful global commercialization for our XL range of Analyzers, India’s first and only Automated Biochemistry Analyzer – 2005

· ‘National Quality Award’ and ‘National Export Award’ in 2000

Marketing & Corporate Communications department
Sangeeta Mishra Priya Pinto/ Monika
p.priya@transasia.co.in / b.monika@transasia.co.in
m.sangeeta@transasia.co.in
Ph: 40309000 /40309022 /40309021

Browse all Transasia Bio-Medicals Ltd press release » | Subscribe to daily press alerts via email »

For more information, Please contact:

Sangeeta Mishra
Head - MARCOM division
Transasia Bio-Medicals Ltd


Fax: 28573030

You can also visit www.transasia.co.in for more information.

Get Daily PR AlertsSubscribe to daily business news/press release alerts: